Activating germ-line point mutations in the RET receptor are responsible for multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma (MTC), whereas somatic RET rearrangements are prevalent in papillary thyroid carcinomas (PTCs). Some rare kindreds, carrying point mutations in RET, are affected by both cancer types, suggesting that, under specific circumstances, point mutations in RET can drive the generation of PTC. Here we describe a family whose siblings, affected by both PTC and MTC, carried a germ-line point mutation in the RET extracellular domain, converting cysteine 634 into serine. We tested on thyroid follicular cells the transforming activity of RET(C634S), RET(K603Q), another mutant identified in a kindred with both PTC and MTC, RET(C634R) a commonly isolated allele in MEN2A, RET(M918T) responsible for MEN2B and also identified in kindreds with both PTC and MTC, and RET/ PTC1 the rearranged oncogene that characterizes bona fide PTC in patients without MTC. We show that the various RET point mutants, but not wild-type RET, scored constitutive kinase activity and exerted mito- Medullary thyroid carcinoma (MTC) is a malignant tumor arising from neural crest-derived calcitonin-secreting C cells of the thyroid, 1 whereas papillary thyroid carcinoma (PTC) derives from endoderm-derived follicular cells. 2 MTC often occurs in the context of autosomal dominant multiple endocrine neoplasia type 2 syndromes (MEN2), whereas PTC is sporadic in most of the cases. 3 This notwithstanding, some rare MEN2 kindreds are affected by both cancer types, the molecular mechanism for this association still remaining unclear.Both MTC and PTC are strictly linked to activating mutations in the RET gene. RET is a transmembrane tyrosine kinase receptor for glial-derived neurotrophic factor (GDNF). 4 RET rearrangements, caused by chromosomal inversions or translocations, are present in 20 to 40% of cases of PTC. 5 These rearrangements result in